Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Maintains Overweight on iRhythm Technologies, Lowers Price Target to $165

Morgan Stanley analyst Cecilia Furlong maintains iRhythm Technologies (NASDAQ:IRTC) with a Overweight and lowers the price target from $172 to $165.
byBenzinga Newsdesk
October 11, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Morgan Stanley analyst Cecilia Furlong maintains iRhythm Technologies (NASDAQ:IRTC) with a Overweight and lowers the price target from $172 to $165.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

2 High Yielding Investments For Investors Looking For Strong Fundamentals And Growing Dividends

By Robert Kuczmarski
September 17, 3:00 PM
When large companies are seeing expanding revenues during macroeconomic headwinds, this can be a positive sign of a strong corporation. With inflation and interest rates on the rise, investors may want to turn to stocks with solid fundamentals that are able to increase their dividend payment per share.

APA